After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Korea JoongAng Daily on MSN
Samsung Epis targets nine additional biosimilars, drug development expansion in growth strategy
Samsung Epis Holdings, the new holding company for Samsung Bioepis, is pursuing a bold expansion strategy focused on pipeline ...
The landscape of drug development is rapidly evolving, with a pressing need for innovative strategies that account for the intricacies of individual patient responses. Pharmacokinetics, the study of ...
Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...
ATLANTA and MISSISSAUGA, ON, May 28, 2025 /PRNewswire/ -- Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and manufacturing ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback